Skip to main content

Table 2 General results regarding the minimally important difference (MID) determination (N = 46)

From: Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review

 

Number

Percent

Approach used for MID determination

 Distribution-based only

3

6.5

 Anchor-based only

6

13.1

 Both distribution- and anchor-based

37

80.4

Term used to design the MID

 MID, referring to:

29

63

  Minimally important difference

16

34.8

  Minimal important difference

13

28.2

 MCID, referring to:

19

41.3

  Minimal clinically important difference

16

34.8

  Minimum clinically important difference

2

4.3

  Minimal clinical important difference

1

2.2

 MIC, referring to:

1

2.2

  Minimal important change

1

2.2

Number of assessment timepoints

 1

2

4.4

 2

31

67.4

 3

6

13

  ≥ 4

7

15.2

Time interval between the assessment times

 2 days

1

2.2

 1 month

7

15.2

 3–6 months

6

13

 1 year

2

4.4

 Based on clinical relevance

3

6.5

 Multiple with a maximum interval of 6 months

14

30.4

 Multiple with a maximum interval > 1 year

5

10.9

 Multiple intervals based on clinical relevance

2

4.4

Floor and ceiling effects studied

 Yes

7

15.2

  Floor and ceiling effects detected (<  15%)

2

28.6

  Floor and ceiling effects no detected (<  15%)

4

57.1

  Not reported

1

14.3

 No

39

84.8

Recommendations for futures studies

 Yes

16

34.8

 No

23

50

 Unclear

7

15.2

Limitations highlighted by authors

 Yes

42

91.3

 No

4

8.7

Possible risk of bias

 Missing data on the HRQOL/PRO measures

16

40

 Bias in the selection of the population

17

42.5

 Bias in the statistical analysis

5

10.9